USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Sep 5, 2022 | Jun 2022 | $0.00 | - | $-0.43 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Sep 5, 2022 | Jun 2022 | $0.00 | - | $0.00 |
Forte Biosciences's next earnings date is Monday, Sep 5, 2022 for the fiscal quarter ending Jun 2022.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Jun 2022 | 0 | $0.00 | $0.00 | $0.00 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 2 | $-0.93 | $-1.09 | $-0.77 |
| Dec 2023 | 2 | $-1.01 | $-1.23 | $-0.79 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Jun 2022 | 0 / 0 | $-0.19 | $-0.19 | $-0.19 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2022 | 0 / 0 | $-0.93 | $-0.93 | $-0.93 |
| Dec 2023 | 0 / 0 | $-1.01 | $-1.01 | $-1.01 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|---|---|---|---|
| Jun 2022 | 1 | $0.00 | $0.00 | $0.00 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 2 | $0.00 | $0.00 | $0.00 |
| Dec 2023 | 2 | $0.00 | $0.00 | $0.00 |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Mar 22, 2022 | Dec 2021 | $-0.32 | $-0.21 | 34.38% |
| Nov 8, 2021 | Sep 2021 | $-0.37 | $-0.54 | -44.97% |
| Aug 16, 2021 | Jun 2021 | $-0.44 | $-0.43 | 1.53% |
| May 10, 2021 | Mar 2021 | $-0.49 | $-0.36 | 26.71% |
| Mar 16, 2021 | Dec 2020 | $-0.59 | $1.04 | 275.29% |
| Nov 9, 2020 | Sep 2020 | $-0.31 | $-0.45 | -47.54% |
| Aug 10, 2020 | Jun 2020 | $-0.18 | $-0.74 | -311.50% |
| Apr 23, 2020 | Mar 2020 | $-6.60 | $-6.45 | 2.27% |
| Feb 27, 2020 | Dec 2019 | $-8.55 | $-7.50 | 12.28% |
| Nov 12, 2019 | Sep 2019 | $-10.49 | $-11.70 | -11.53% |
| Aug 8, 2019 | Jun 2019 | $-11.34 | $-10.80 | 4.76% |
| May 7, 2019 | Mar 2019 | $-15.15 | $-11.10 | 26.73% |
| Feb 27, 2019 | Dec 2018 | $-10.26 | $-14.40 | -40.35% |
| Nov 8, 2018 | Sep 2018 | $-6.75 | $-0.30 | 95.56% |
| Aug 7, 2018 | Jun 2018 | $-8.90 | $-12.15 | -36.52% |
| May 10, 2018 | Mar 2018 | - | $-9.71 | - |
| Mar 8, 2018 | Dec 2017 | $-0.62 | $-0.55 | 11.29% |
| Nov 8, 2017 | Sep 2017 | $-0.57 | $-0.50 | 12.28% |
| Aug 9, 2017 | Jun 2017 | $-0.52 | $-0.56 | -7.69% |
| Apr 13, 2017 | Mar 2017 | $-2.69 | $-4.11 | -52.79% |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Mar 22, 2022 | Dec 2021 | $-1.54 | $-1.54 | - |
| Mar 16, 2021 | Dec 2020 | $-8.58 | $-6.60 | - |
| Feb 27, 2020 | Dec 2019 | - | $-41.10 | - |
| Feb 27, 2019 | Dec 2018 | - | $-36.56 | - |
| Mar 8, 2018 | Dec 2017 | - | $-5.72 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Mar 22, 2022 | Dec 2021 | $0.00 | - | - |
| Nov 8, 2021 | Sep 2021 | $0.00 | $0.00 | - |
| Aug 16, 2021 | Jun 2021 | $0.00 | $0.00 | - |
| May 10, 2021 | Mar 2021 | $0.00 | $0.00 | - |
| Mar 16, 2021 | Dec 2020 | $0.00 | $0.00 | - |
| Nov 9, 2020 | Sep 2020 | $0.00 | $0.00 | - |
| Aug 10, 2020 | Jun 2020 | $0.00 | $0.00 | - |
| Apr 23, 2020 | Mar 2020 | - | $9.00K | - |
| Feb 27, 2020 | Dec 2019 | - | $9.00K | - |
| Nov 12, 2019 | Sep 2019 | - | $9.00K | - |
| Aug 8, 2019 | Jun 2019 | - | $9.00K | - |
| May 7, 2019 | Mar 2019 | - | $9.00K | - |
| Feb 27, 2019 | Dec 2018 | - | - | - |
| Nov 8, 2018 | Sep 2018 | - | - | - |
| Aug 7, 2018 | Jun 2018 | - | - | - |
| May 10, 2018 | Mar 2018 | - | - | - |
| Mar 8, 2018 | Dec 2017 | - | - | - |
| Nov 8, 2017 | Sep 2017 | - | - | - |
| Aug 9, 2017 | Jun 2017 | - | - | - |
| Apr 13, 2017 | Mar 2017 | - | - | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Mar 22, 2022 | Dec 2021 | $0.00 | - | - |
| Mar 16, 2021 | Dec 2020 | $0.00 | $0.00 | - |
| Feb 27, 2020 | Dec 2019 | - | $36.00K | - |
| Feb 27, 2019 | Dec 2018 | - | $18.04M | - |
| Mar 8, 2018 | Dec 2017 | - | $41.00K | - |
FBRX's next earnings date is Monday, Sep 5, 2022 for the fiscal quarter ending Jun 30, 2022.
According to analysts, the average EPS estimation for Forte Biosciences's next quarterly earnings is $0.00, with a low EPS estimation of $0.00, and a high estimation of $0.00.
Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.19, the last 2 month trend is $-0.19, and the 3 month trend is $-0.19.
Based on analysts, the average revenue estimation is $0.00, with a low revenue estimation of $0.00, and a high estimation of $0.00.
Forte Biosciences's previous earnings date was May 9, 2022 for its fiscal quarter ended Mar 31, 2022.
Forte Biosciences's previous annual earnings date was Mar 22, 2022 for its fiscal year ended Dec 31, 2021.
FBRX's earnings per share (EPS) was $-1.54, beating the consensus analysts forecast of $-1.54 by 0.00% , and higher than the previous year's EPS (Dec 2020) by -76.67%.
The company reported a net income of $-21.71M.
Forte Biosciences reported a free cash flow of $-16.62M for its fiscal year, compared to $-18.42M a year ago.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.
